标题
Splice-switching antisense oligonucleotides as therapeutic drugs
作者
关键词
-
出版物
NUCLEIC ACIDS RESEARCH
Volume 44, Issue 14, Pages 6549-6563
出版商
Oxford University Press (OUP)
发表日期
2016-06-11
DOI
10.1093/nar/gkw533
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy
- (2016) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides
- (2016) A. J. Hinrich et al. EMBO Molecular Medicine
- In vitroandin vivorescue of aberrant splicing inCEP290-associated LCA by antisense oligonucleotide delivery
- (2016) Alejandro Garanto et al. HUMAN MOLECULAR GENETICS
- Defective control of pre–messenger RNA splicing in human disease
- (2016) Benoit Chabot et al. JOURNAL OF CELL BIOLOGY
- Intrathecal Injections in Children With Spinal Muscular Atrophy
- (2016) Manon Haché et al. JOURNAL OF CHILD NEUROLOGY
- Modulation of LMNA splicing as a strategy to treat prelamin A diseases
- (2016) John M. Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- Directed Alternative Splicing in Nijmegen Breakage Syndrome: Proof of Principle Concerning Its Therapeutical Application
- (2016) Bastian Salewsky et al. MOLECULAR THERAPY
- Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
- (2016) Claudia A. Chiriboga et al. NEUROLOGY
- The delivery of therapeutic oligonucleotides
- (2016) Rudolph L. Juliano NUCLEIC ACIDS RESEARCH
- The 3.8 A structure of the U4/U6.U5 tri-snRNP: Insights into spliceosome assembly and catalysis
- (2016) R. Wan et al. SCIENCE
- The Spliceosome: The Ultimate RNA Chaperone and Sculptor
- (2016) Panagiotis Papasaikas et al. TRENDS IN BIOCHEMICAL SCIENCES
- Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice
- (2016) Gang Han et al. Nature Communications
- Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
- (2015) Richard S. Geary et al. ADVANCED DRUG DELIVERY REVIEWS
- Antisense oligonucleotides in therapy for neurodegenerative disorders
- (2015) Melvin M. Evers et al. ADVANCED DRUG DELIVERY REVIEWS
- The Clothes Make the mRNA: Past and Present Trends in mRNP Fashion
- (2015) Guramrit Singh et al. Annual Review of Biochemistry
- Mechanisms and Regulation of Alternative Pre-mRNA Splicing
- (2015) Yeon Lee et al. Annual Review of Biochemistry
- Validation of a high resolution NGS method for detecting spinal muscular atrophy carriers among phase 3 participants in the 1000 Genomes Project
- (2015) Jessica L. Larson et al. BMC Medical Genetics
- An update on RNA-targeting therapies for neuromuscular disorders
- (2015) Silvana Jirka et al. CURRENT OPINION IN NEUROLOGY
- An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies
- (2015) Graham McClorey et al. CURRENT OPINION IN PHARMACOLOGY
- Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy
- (2015) M. Gramlich et al. EMBO Molecular Medicine
- Gene and splicing therapies for neuromuscular diseases
- (2015) Aurelie Goyenvalle Frontiers in Bioscience-Landmark
- Oligonucleotide therapeutics: chemistry, delivery and clinical progress
- (2015) Vivek K Sharma et al. Future Medicinal Chemistry
- Motor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse models
- (2015) Yimin Hua et al. GENES & DEVELOPMENT
- Gene-targeting pharmaceuticals for single-gene disorders
- (2015) Arthur L. Beaudet et al. HUMAN MOLECULAR GENETICS
- Antisense oligonucleotide–mediated MDM4 exon 6 skipping impairs tumor growth
- (2015) Michael Dewaele et al. JOURNAL OF CLINICAL INVESTIGATION
- Disease Mechanisms and Therapeutic Approaches in Spinal Muscular Atrophy
- (2015) S. Tisdale et al. JOURNAL OF NEUROSCIENCE
- Combination Antisense Treatment for Destructive Exon Skipping of Myostatin and Open Reading Frame Rescue of Dystrophin in Neonatal mdx Mice
- (2015) Ngoc B Lu-Nguyen et al. MOLECULAR THERAPY
- Spinal Muscular Atrophy
- (2015) Stephen J. Kolb et al. NEUROLOGIC CLINICS
- Challenges of clinical trial design for DMD
- (2015) Valeria Ricotti et al. NEUROMUSCULAR DISORDERS
- Prevalence of Duchenne and Becker Muscular Dystrophies in the United States
- (2015) P. A. Romitti et al. PEDIATRICS
- Structural basis of pre-mRNA splicing
- (2015) Jing Hang et al. SCIENCE
- An alternative splicing event amplifies evolutionary differences between vertebrates
- (2015) S. Gueroussov et al. SCIENCE
- A Phase I/IIa Clinical Trial in Duchenne Muscular Dystrophy Using Systemically Delivered Morpholino Antisense Oligomer to Skip Exon 53 (SKIP-NMD)
- (2015) Human Gene Therapy Clinical Development
- Dose-Dependent Pharmacokinetic Profiles of 2′-O-Methyl Phosphorothioate Antisense Oligonucleotidesin mdx Mice
- (2015) Ingrid E.C. Verhaart et al. Nucleic Acid Therapeutics
- Deep learning of the tissue-regulated splicing code
- (2014) Michael K. K. Leung et al. BIOINFORMATICS
- Exon skipping restores dystrophin expression, but fails to prevent disease progression in later stage dystrophic dko mice
- (2014) B Wu et al. GENE THERAPY
- Development of Therapeutic Splice-Switching Oligonucleotides
- (2014) Petra Disterer et al. HUMAN GENE THERAPY
- Morpholino antisense oligonucleotides targeting intronic repressor Element1 improve phenotype in SMA mouse models
- (2014) Erkan Y. Osman et al. HUMAN MOLECULAR GENETICS
- Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model
- (2014) Burcu Bestas et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study
- (2014) Thomas Voit et al. LANCET NEUROLOGY
- Bubble Liposomes and Ultrasound Exposure Improve Localized Morpholino Oligomer Delivery into the Skeletal Muscles of Dystrophic mdx Mice
- (2014) Yoichi Negishi et al. MOLECULAR PHARMACEUTICS
- Observational study of spinal muscular atrophy type I and implications for clinical trials
- (2014) R. S. Finkel et al. NEUROLOGY
- Intrathecal delivery of protein therapeutics to the brain: A critical reassessment
- (2014) Pericles Calias et al. PHARMACOLOGY & THERAPEUTICS
- The human splicing code reveals new insights into the genetic determinants of disease
- (2014) H. Y. Xiong et al. SCIENCE
- Induced IL-10 Splice Altering Approach to Antiviral Drug Discovery
- (2014) Rekha G. Panchal et al. Nucleic Acid Therapeutics
- Exon-Skipping Antisense Oligonucleotides to Correct Missplicing in Neurogenetic Diseases
- (2014) Kavitha Siva et al. Nucleic Acid Therapeutics
- Skipping Multiple Exons of Dystrophin Transcripts Using Cocktail Antisense Oligonucleotides
- (2014) Yusuke Echigoya et al. Nucleic Acid Therapeutics
- Preventing Formation of Toxic N-Terminal Huntingtin Fragments Through Antisense Oligonucleotide-Mediated Protein Modification
- (2014) Melvin M. Evers et al. Nucleic Acid Therapeutics
- Phosphorothioates, Essential Components of Therapeutic Oligonucleotides
- (2014) Fritz Eckstein Nucleic Acid Therapeutics
- Alternative Splice Forms of CTLA-4 Induced by Antisense Mediated Splice-Switching Influences Autoimmune Diabetes Susceptibility in NOD Mice
- (2014) Dan V. Mourich et al. Nucleic Acid Therapeutics
- Exon identity crisis: disease-causing mutations that disrupt the splicing code
- (2014) Timothy Sterne-Weiler et al. GENOME BIOLOGY
- What Can We Learn From Clinical Trials of Exon Skipping for DMD?
- (2014) Qi-long Lu et al. Molecular Therapy-Nucleic Acids
- A Short Antisense Oligonucleotide Ameliorates Symptoms of Severe Mouse Models of Spinal Muscular Atrophy
- (2014) Jeffrey M Keil et al. Molecular Therapy-Nucleic Acids
- Eteplirsen for the treatment of Duchenne muscular dystrophy
- (2013) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Directing HER4 mRNA expression towards the CYT2 isoform by antisense oligonucleotide decreases growth of breast cancer cells in vitro and in vivo
- (2013) T O Nielsen et al. BRITISH JOURNAL OF CANCER
- Rescue of cardiomyopathy through U7snRNA-mediated exon skipping inMybpc3-targeted knock-in mice
- (2013) Christina Gedicke-Hornung et al. EMBO Molecular Medicine
- Pathological impact ofSMN2mis-splicing in adult SMA mice
- (2013) Kentaro Sahashi et al. EMBO Molecular Medicine
- A Novel Morpholino Oligomer Targeting ISS-N1 Improves Rescue of Severe Spinal Muscular Atrophy Transgenic Mice
- (2013) Haiyan Zhou et al. HUMAN GENE THERAPY
- Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy
- (2013) Taeyoung Koo et al. HUMAN GENE THERAPY
- Exon Skipping of Hepatic APOB Pre-mRNA With Splice-switching Oligonucleotides Reduces LDL Cholesterol In Vivo
- (2013) Petra Disterer et al. MOLECULAR THERAPY
- Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy
- (2013) Jerry R. Mendell et al. MUSCLE & NERVE
- Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness
- (2013) Jennifer J Lentz et al. NATURE MEDICINE
- Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: Removal of the CAG containing exon
- (2013) Melvin M. Evers et al. NEUROBIOLOGY OF DISEASE
- 195th ENMC International Workshop: Newborn screening for Duchenne muscular dystrophy 14–16th December, 2012, Naarden, The Netherlands
- (2013) Juliet A. Ellis et al. NEUROMUSCULAR DISORDERS
- Improved Antisense Oligonucleotide Design to Suppress Aberrant SMN2 Gene Transcript Processing: Towards a Treatment for Spinal Muscular Atrophy
- (2013) Chalermchai Mitrpant et al. PLoS One
- Characterization of Target mRNA Reduction Through In Situ RNA Hybridization in Multiple Organ Systems Following Systemic Antisense Treatment in Animals
- (2013) Gene Hung et al. Nucleic Acid Therapeutics
- Ultrasound-enhanced delivery of Morpholino with Bubble liposomes ameliorates the myotonia of myotonic dystrophy model mice
- (2013) Michinori Koebis et al. Scientific Reports
- Targeting RNA splicing for disease therapy
- (2013) Mallory A. Havens et al. Wiley Interdisciplinary Reviews-RNA
- Inhibition of IL-1 Signaling by Antisense Oligonucleotide-mediated Exon Skipping of IL-1 Receptor Accessory Protein (IL-1RAcP)
- (2013) A Seda Yılmaz-Eliş et al. Molecular Therapy-Nucleic Acids
- Antisense Oligonucleotide-Mediated Exon Skipping for Duchenne Muscular Dystrophy: Progress and Challenges
- (2012) Virginia Arechavala-Gomeza et al. CURRENT GENE THERAPY
- Use of Cell-Penetrating-Peptides in Oligonucleotide Splice Switching Therapy
- (2012) Samir A. El Andaloussi et al. CURRENT GENE THERAPY
- Dual suppression of hemangiogenesis and lymphangiogenesis by splice-shifting morpholinos targeting vascular endothelial growth factor receptor 2 (KDR)
- (2012) Hironori Uehara et al. FASEB JOURNAL
- Pathophysiological Insights Derived by Natural History and Motor Function of Spinal Muscular Atrophy
- (2012) Michelle A. Farrar et al. JOURNAL OF PEDIATRICS
- Childhood spinal muscular atrophy: controversies and challenges
- (2012) Eugenio Mercuri et al. LANCET NEUROLOGY
- Targeting a pre-mRNA structure with bipartite antisense molecules modulates tau alternative splicing
- (2012) Eleanor Peacey et al. NUCLEIC ACIDS RESEARCH
- Morpholino-Mediated Increase in Soluble Flt-1 Expression Results in Decreased Ocular and Tumor Neovascularization
- (2012) Leah A. Owen et al. PLoS One
- Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery
- (2012) Y. Aoki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Evolutionary Landscape of Alternative Splicing in Vertebrate Species
- (2012) N. L. Barbosa-Morais et al. SCIENCE
- Antisense oligonucleotide therapeutics for inherited neurodegenerative diseases
- (2012) Amber L. Southwell et al. TRENDS IN MOLECULAR MEDICINE
- Long-term Exon Skipping Studies With 2′-O-Methyl Phosphorothioate Antisense Oligonucleotides in Dystrophic Mouse Models
- (2012) Christa L Tanganyika-de Winter et al. Molecular Therapy-Nucleic Acids
- Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment
- (2012) Corinne Betts et al. Molecular Therapy-Nucleic Acids
- Locked vs. unlocked nucleic acids (LNA vs. UNA): contrasting structures work towards common therapeutic goals
- (2011) Meghan A. Campbell et al. CHEMICAL SOCIETY REVIEWS
- More than a splicing code: integrating the role of RNA, chromatin and non-coding RNA in alternative splicing regulation
- (2011) Reini F Luco et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens
- (2011) Elaine A Sugarman et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse
- (2011) Paul N. Porensky et al. HUMAN MOLECULAR GENETICS
- Chemical and Mechanistic Toxicology Evaluation of Exon Skipping Phosphorodiamidate Morpholino Oligomers in mdx Mice
- (2011) Peter Sazani et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Repeat-Dose Toxicology Evaluation in Cynomolgus Monkeys of AVI-4658, a Phosphorodiamidate Morpholino Oligomer (PMO) Drug for the Treatment of Duchenne Muscular Dystrophy
- (2011) Peter Sazani et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
- (2011) Sebahattin Cirak et al. LANCET
- Induction of Antagonistic Soluble Decoy Receptor Tyrosine Kinases by Intronic PolyA Activation
- (2011) Sandra Vorlová et al. MOLECULAR CELL
- Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy
- (2011) Mariko Taniguchi-Ikeda et al. NATURE
- Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
- (2011) Yimin Hua et al. NATURE
- Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
- (2011) Nathalie M. Goemans et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes
- (2011) Erich Koller et al. NUCLEIC ACIDS RESEARCH
- Antitumorigenic potential of STAT3 alternative splicing modulation
- (2011) F. Zammarchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Splicing-Directed Therapy in a New Mouse Model of Human Accelerated Aging
- (2011) F. G. Osorio et al. Science Translational Medicine
- Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
- (2011) M. A. Passini et al. Science Translational Medicine
- Newborn and carrier screening for spinal muscular atrophy
- (2010) Thomas W. Prior et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Morpholinos and their peptide conjugates: Therapeutic promise and challenge for Duchenne muscular dystrophy
- (2010) Hong M. Moulton et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
- (2010) Y. Hua et al. GENES & DEVELOPMENT
- A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity
- (2010) S. Cho et al. GENES & DEVELOPMENT
- Safety Pharmacology and Genotoxicity Evaluation of AVI-4658
- (2010) Peter Sazani et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Antisense-induced Myostatin Exon Skipping Leads to Muscle Hypertrophy in Mice Following Octa guanidine Morpholino Oligomer Treatment
- (2010) Jagjeet K Kang et al. MOLECULAR THERAPY
- Deciphering the splicing code
- (2010) Yoseph Barash et al. NATURE
- Anti-tumor activity of splice-switching oligonucleotides
- (2010) John A. Bauman et al. NUCLEIC ACIDS RESEARCH
- A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy
- (2010) Natalia N. Singh et al. RNA Biology
- Spliceosome Structure and Function
- (2010) C. L. Will et al. Cold Spring Harbor Perspectives in Biology
- Efficacy of systemic morpholino exon-skipping in duchenne dystrophy dogs
- (2009) Toshifumi Yokota et al. ANNALS OF NEUROLOGY
- Genotype-phenotype studies in infantile spinal muscular atrophy (SMA) type I in Germany: implications for clinical trials and genetic counselling
- (2009) S Rudnik-Schöneborn et al. CLINICAL GENETICS
- Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation
- (2009) D. Merrick et al. Disease Models & Mechanisms
- Antisense oligonucleotide pharmacokinetics and metabolism
- (2009) Richard S Geary Expert Opinion on Drug Metabolism & Toxicology
- In vivocomparison of 2′-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping
- (2009) Hans A. Heemskerk et al. JOURNAL OF GENE MEDICINE
- Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
- (2009) Maria Kinali et al. LANCET NEUROLOGY
- Gene Knockdowns in Adult Animals: PPMOs and Vivo-Morpholinos
- (2009) Jon Moulton et al. MOLECULES
- RNA repair restores hemoglobin expression in IVS2-654 thalassemic mice
- (2009) S. Svasti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antisense Masking of an hnRNP A1/A2 Intronic Splicing Silencer Corrects SMN2 Splicing in Transgenic Mice
- (2008) Yimin Hua et al. AMERICAN JOURNAL OF HUMAN GENETICS
- An Endogenous TNF-α Antagonist Induced by Splice-switching Oligonucleotides Reduces Inflammation in Hepatitis and Arthritis Mouse Models
- (2008) Maria A Graziewicz et al. MOLECULAR THERAPY
- Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
- (2008) Qun Pan et al. NATURE GENETICS
- Splicing regulation: From a parts list of regulatory elements to an integrated splicing code
- (2008) Z. Wang et al. RNA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More